You Position: Home > Paper
整合素β1对卵巢癌细胞耐药的影响研究
( views:157, downloads:0 )
- Author:
- No author available
- Journal Title:
- MATERNAL AND CHILD HEALTH CARE OF CHINA
- Issue:
- 35
- DOI:
- 10.3969/j.issn.1001-4411.2007.35.067
- Key Word:
- No keyword available
Abstract： @@ 卵巢癌(Ovarian cancer)死亡率居妇科恶性肿瘤之首,由于缺乏特异的临床症状及相应的早期诊断手段,约70%的患者发现时已届晚期.尽管目前临床上采取积极而彻底的肿瘤细胞减灭术,辅以顺铂为基础的联合化疗,其临床完全缓解率不过40%～60%,致使5年生存率长期徘徊在15%～30%之间,难望有进一步的提高[1].
- [1]A, van der Flier,A, Sonnenberg.Function and interactions of integrins.[J].2001,305(3).
- [2]Muthu, Selvakumaran,Debra A, Pisarcik,Rudi, Bao,etc.Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.[J].2003,63(6).
- [3]Kramer RH,Kantak SS.E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells.[J].1998,273(27).
- [4]K, Lessan,D J, Aguiar,T, Oegema,etc.CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells.[J].1999,154(5).
- [5]H, Liapis,L M, Adler,M R, Wick,etc.Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas.[J].1997,28(4).
- [6]S A, Cannistra,C, Ottensmeier,J, Niloff,etc.Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer.[J].1995,58.
- [7]I, Goldberg,B, Davidson,R, Reich,etc.Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.[J].2001,7(12).
- [8]Screaton RA,Frisch SM urnham-inst.org.Anoikis mechanisms.[J].2001,13(5).
- [9]Ben, Davidson,Iris, Goldberg,Reuven, Reich,etc.AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.[J].2003,90(2).
- [10]Quinn JE,Johnston PG,Harkin DP,etc.The role of BRCA1 in the cellular response to chemotherapy.[J].2004,96(22).
- [11]Muller-Klingspor V,Kaider A,Leodolte S,etc.Prognostic value of beta1-integrin (=CD29) in serous adenocarcinomas of the ovary.[J].2001,21(3C).
- [12]Ridgway LD,Siddik ZH,Mills GB,etc.Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.[J].2003,278(21).
- [13]S M, Ellerbroek,D A, Fishman,A S, Kearns,etc.Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin.[J].1999,59(7).
- [14]J A, Buczek-Thomas,N, Chen,T, Hasan.Integrin-mediated adhesion and signalling in ovarian cancer cells.[J].1998,10(1).